Publications by authors named "Rachel B Dunn"
Objective: To assess the real-world efficacy, tolerability, and safety of ubrogepant in a tertiary headache center.
Background: The efficacy and safety of ubrogepant for the acute treatment of migraine were established in phase 3 randomized controlled trials. However, there is no real-world data of patient experience with ubrogepant in a population in which the majority of patients have chronic migraine, multiple prior unsuccessful treatments, complex medical comorbidities, and concurrent use of other migraine-specific medications.